CompletedNot Applicable

Cancellous Bone Autograft, Bone Substitute, Local Antibiotic, and Fresh Blood for Ununited Fixed Femoral and Tibial Fractures

Egypt25 participantsStarted 2023-07-01

Plain-language summary

This study aimed to assess the clinical and radiological outcomes of the usage of autogenous bone graft mixed with bone substitute, fresh blood of patient and local antibiotic used as an onlay graft in treatment of nonunion or delayed union of fixed femoral and tibia fractures.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age from 18 to 70 years old. * Both sexes. * Patients with complete radiographic and clinical follow-up records for at least 12 months post-revision. Exclusion Criteria: \- Patients with pathological fractures, infection, or comorbidities that interfere with healing.

What they're measuring

Radiographic union of the fractures

Timeframe: 6 months post-procedure

Trial details

NCT IDNCT07561788

SponsorTanta University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-01

View on ClinicalTrials.gov More Cancellous Bone Autograft trials